Recent Advances in Drug Repurposing for Parkinson's Disease
| Autor: | Xin Chen, Kristopher G. Virga, Giuseppe Gumina |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
medicine.medical_specialty
Parkinson's disease Degenerative Disorder Population Disease Biochemistry 03 medical and health sciences 0302 clinical medicine Drug Discovery medicine Animals Humans education Intensive care medicine 030304 developmental biology Pharmacology 0303 health sciences education.field_of_study Molecular Structure Drug discovery Organic Chemistry Neurodegeneration Disease progression Drug Repositioning Parkinson Disease medicine.disease Drug repositioning Neuroprotective Agents Molecular Medicine 030217 neurology & neurosurgery |
| Zdroj: | Current medicinal chemistry. 26(28) |
| ISSN: | 1875-533X |
| Popis: | As a long-term degenerative disorder of the central nervous system that mostly affects older people, Parkinson’s disease is a growing health threat to our ever-aging population. Despite remarkable advances in our understanding of this disease, all therapeutics currently available only act to improve symptoms but cannot stop the disease progression. Therefore, it is essential that more effective drug discovery methods and approaches are developed, validated, and used for the discovery of disease-modifying treatments for Parkinson’s disease. Drug repurposing, also known as drug repositioning, or the process of finding new uses for existing or abandoned pharmaceuticals, has been recognized as a cost-effective and timeefficient way to develop new drugs, being equally promising as de novo drug discovery in the field of neurodegeneration and, more specifically for Parkinson’s disease. The availability of several established libraries of clinical drugs and fast evolvement in disease biology, genomics and bioinformatics has stimulated the momentums of both in silico and activity-based drug repurposing. With the successful clinical introduction of several repurposed drugs for Parkinson’s disease, drug repurposing has now become a robust alternative approach to the discovery and development of novel drugs for this disease. In this review, recent advances in drug repurposing for Parkinson’s disease will be discussed. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|